Cold & Cough Remedies (Pharmacies) - Germany

Revenue in the Cold & Cough Remedies market is projected to reach US$1.23bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 4.94%, resulting in a market volume of US$1.56bn by 2029.
In global comparison, most revenue will be generated China (US$7.83bn in 2024).
In relation to total population figures, per person revenues of US$14.72 are generated in 2024.

Definition:
The Cold and Cough market encompasses a range of over-the-counter (OTC) products sold through pharmacies. These products include both natural and synthetic agents designed to alleviate symptoms related to cough, cold, sore throat, expectorants, and flu-like infections. The market includes various forms of medication such as pills, syrups, lozenges, sprays, ointments, and granulates for both external and internal usage. However, the market excludes prescription medicines, products contrary to state regulations, or those not explicitly designed for cold or cough relief, such as painkillers. Some of the leading products in this market include nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, and Isla Moos. This market exclusively covers product sales through pharmacies.

Additional Information:
The Cold and Cough market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
In the form of pills, syrups, creams, lozenges, sprays and granulate
Expectorants and remedies to relieve cough

Prescription medicines
Homeopathic remedies
Painkillers
Candy

The Cold & Cough Remedies (Pharmacies) market in Germany is experiencing significant growth due to various factors.

Customer preferences: Customers in Germany have shown a strong preference for over-the-counter cold and cough remedies purchased from pharmacies. This preference is driven by the convenience and accessibility of pharmacies, as well as the trust placed in pharmacists to provide expert advice on the most suitable remedies. Additionally, customers in Germany tend to prioritize natural and herbal remedies, leading to an increase in demand for cold and cough remedies with natural ingredients.

Trends in the market: One of the key trends in the Cold & Cough Remedies (Pharmacies) market in Germany is the growing demand for preventive remedies. Customers are increasingly seeking products that can boost their immune system and help prevent colds and coughs. This trend is driven by a growing awareness of the importance of maintaining a healthy immune system and the desire to avoid the inconvenience and discomfort of falling ill. Another trend in the market is the increasing popularity of combination remedies. Customers are looking for products that can provide relief for multiple symptoms, such as congestion, cough, and sore throat, in a single dose. Combination remedies offer convenience and cost savings, as customers do not need to purchase multiple products to address different symptoms.

Local special circumstances: Germany has a well-developed healthcare system, with a strong emphasis on preventive care. This focus on preventive care extends to the treatment of colds and coughs, with customers seeking remedies that can help prevent illness or alleviate symptoms at the earliest stages. Additionally, Germany has a high level of health consciousness among its population, leading to a demand for natural and herbal remedies.

Underlying macroeconomic factors: The growth of the Cold & Cough Remedies (Pharmacies) market in Germany is also influenced by macroeconomic factors. Germany has a stable economy with a high level of disposable income, allowing customers to prioritize their health and wellness. Additionally, the aging population in Germany contributes to the growth of the market, as older individuals are more susceptible to colds and coughs and are more likely to seek remedies from pharmacies. In conclusion, the Cold & Cough Remedies (Pharmacies) market in Germany is experiencing growth due to customer preferences for over-the-counter remedies, the demand for preventive and combination remedies, local special circumstances such as a focus on preventive care and health consciousness, and underlying macroeconomic factors including a stable economy and an aging population.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.